{"object_type":"df_transaction_reference","event_type":null,"buyer":"Altaris","seller":"Clarivate","asset_description":"Life Sciences & Healthcare segment, including trusted data assets and analytics spanning drug and device development","reported_price":"$600,000,000","confidence":"High","region":"US\/UK\/global","_attribution":{"source":"DatFlash","publisher":"DataUniversa","retrieved":"2026-10-06","note":"Observed transaction reference. No normalization or appraisal applied."}}